Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus oral paracetamol for patent ductus arteriosus in very low birth weight preterm neonates
ACTRN12613000289718Phase 3Recruiting
- Sponsor
- Sapienza University of Rome
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Sapienza University of Rome. Primary endpoint: Ductal closure. Started Apr 2013; status: recruiting.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on ACTRN12613000289718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000289718.